Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...

Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.

Story May 1 - Arvinas: After Arvinas announced during its Q1 results presentation that the biotech and partner Pfizer are dropping ... pharma is planning to cut 163 jobs at its Cherokee ...